ICYMI: LA TIMES – VACCINE MAKER GOT $1 BILLION FROM TAXPAYERS. NOW IT’S BOOSTING DRUG PRICES
Brand Name Drug Maker AstraZeneca Aggressively Raised Prices In The Middle Of… Read More
Brand Name Drug Maker AstraZeneca Aggressively Raised Prices In The Middle Of… Read More
Report Finds Just Five Instances Of Product Hopping Sticks Americans With $4.7… Read More
Tweet Misstates Impact of Misguided Rebate Rule That Would Do Nothing to Lower… Read More
Study Finds Rebates Negotiated By PBMs Reduce Rx Costs and Lower Premiums –… Read More
U.S. House Oversight Committee Subpoena of AbbVie Related to Pricing of… Read More
Administration Should Shelve Rebate Rule That Would Increase Medicare… Read More
Tracking Data Finds Drug Companies Increased Prices On at Least 67 Brand Name… Read More
White House Should Reject Pharma-Backed Policies That Would Hand Drug… Read More
Misguided Measure Would Increase Medicare Part D Premiums, Cost Taxpayers More… Read More
Drug Companies Target PBMs and Rebates That Play a Critical Role in Lowering… Read More
Brand Name Drug Company Completes Sweep of Big Pharma Giants Who Beat Wall… Read More
Encourages Administration to Reject Measure That Would Increase Premiums on… Read More